Global SPECT Radiopharmaceuticals Market Research Report 2026(Status and Outlook)
Description
Report Overview
SPECT (Single Photon Emission Computed Tomography) radiopharmaceuticals are compounds that contain a radioactive isotope used in conjunction with SPECT imaging techniques. These radiopharmaceuticals emit gamma radiation, which is detected by a gamma camera during a SPECT scan, creating detailed 3D images of the internal structures and functions of the body. These radiopharmaceuticals are primarily used for diagnostic imaging, allowing healthcare providers to evaluate the function of organs, tissues, and systems without invasive procedures.SPECT radiopharmaceuticals are a type of radioactive tracers used in nuclear medicine imaging that can help doctors detect heart disease, neurological diseases, cancer, bone diseases, and thyroid diseases. They rely on short-half-life radioisotopes to obtain physiological function information through SPECT scanners, and have important applications in modern medicine.From a regional perspective, North America and Europe have advanced medical infrastructure and strong R&D capabilities. As the world's largest radiopharmaceutical market, they have promoted the widespread use of SPECT radiopharmaceuticals. The increase in medical demand in emerging markets such as Asia Pacific and Latin America will provide new growth momentum for the SPECT radiopharmaceutical market.Global leading suppliers include GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Curium Pharma, etc. The production of radiopharmaceuticals requires complex nuclear technology and strict safety supervision. These high technical barriers limit the entry of new companies and maintain the stability of the market.With the advancement of medical technology, new radioisotopes and labeling methods will be developed to improve the accuracy and efficiency of SPECT imaging and promote market development.
The global SPECT Radiopharmaceuticals market size was estimated at USD 5169.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 16.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global SPECT Radiopharmaceuticals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global SPECT Radiopharmaceuticals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the SPECT Radiopharmaceuticals market.
Global SPECT Radiopharmaceuticals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GE Healthcare
Cardinal Health
Lantheus Medical Imaging
Bracco Imaging
Curium Pharma
Eczacibasi-Monrol
Siemens Healthineers
Bayer (Radiology Division)
Molecular Imaging, Inc.
NorthStar Medical Radioisotopes
Advanced Accelerator Applications
IBA Molecular Imaging
Market Segmentation (by Type)
Technetium-99m (Tc-99m) Based Agents
Iodine-123 (I-123) Based Agents
Gallium-67 (Ga-67)
Indium-111 (In-111) Based Agents
Thallium-201 (Tl-201)
Market Segmentation (by Application)
Cardiac Imaging
Cancer Imaging
Brain Imaging
Thyroid Imaging
Infection and Inflammation Imaging
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the SPECT Radiopharmaceuticals Market
Overview of the regional outlook of the SPECT Radiopharmaceuticals Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the SPECT Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of SPECT Radiopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
SPECT (Single Photon Emission Computed Tomography) radiopharmaceuticals are compounds that contain a radioactive isotope used in conjunction with SPECT imaging techniques. These radiopharmaceuticals emit gamma radiation, which is detected by a gamma camera during a SPECT scan, creating detailed 3D images of the internal structures and functions of the body. These radiopharmaceuticals are primarily used for diagnostic imaging, allowing healthcare providers to evaluate the function of organs, tissues, and systems without invasive procedures.SPECT radiopharmaceuticals are a type of radioactive tracers used in nuclear medicine imaging that can help doctors detect heart disease, neurological diseases, cancer, bone diseases, and thyroid diseases. They rely on short-half-life radioisotopes to obtain physiological function information through SPECT scanners, and have important applications in modern medicine.From a regional perspective, North America and Europe have advanced medical infrastructure and strong R&D capabilities. As the world's largest radiopharmaceutical market, they have promoted the widespread use of SPECT radiopharmaceuticals. The increase in medical demand in emerging markets such as Asia Pacific and Latin America will provide new growth momentum for the SPECT radiopharmaceutical market.Global leading suppliers include GE Healthcare, Cardinal Health, Lantheus Medical Imaging, Bracco Imaging, Curium Pharma, etc. The production of radiopharmaceuticals requires complex nuclear technology and strict safety supervision. These high technical barriers limit the entry of new companies and maintain the stability of the market.With the advancement of medical technology, new radioisotopes and labeling methods will be developed to improve the accuracy and efficiency of SPECT imaging and promote market development.
The global SPECT Radiopharmaceuticals market size was estimated at USD 5169.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 16.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global SPECT Radiopharmaceuticals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global SPECT Radiopharmaceuticals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the SPECT Radiopharmaceuticals market.
Global SPECT Radiopharmaceuticals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GE Healthcare
Cardinal Health
Lantheus Medical Imaging
Bracco Imaging
Curium Pharma
Eczacibasi-Monrol
Siemens Healthineers
Bayer (Radiology Division)
Molecular Imaging, Inc.
NorthStar Medical Radioisotopes
Advanced Accelerator Applications
IBA Molecular Imaging
Market Segmentation (by Type)
Technetium-99m (Tc-99m) Based Agents
Iodine-123 (I-123) Based Agents
Gallium-67 (Ga-67)
Indium-111 (In-111) Based Agents
Thallium-201 (Tl-201)
Market Segmentation (by Application)
Cardiac Imaging
Cancer Imaging
Brain Imaging
Thyroid Imaging
Infection and Inflammation Imaging
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the SPECT Radiopharmaceuticals Market
Overview of the regional outlook of the SPECT Radiopharmaceuticals Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the SPECT Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of SPECT Radiopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
147 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of SPECT Radiopharmaceuticals
- 1.2 Key Market Segments
- 1.2.1 SPECT Radiopharmaceuticals Segment by Type
- 1.2.2 SPECT Radiopharmaceuticals Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 SPECT Radiopharmaceuticals Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global SPECT Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global SPECT Radiopharmaceuticals Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 SPECT Radiopharmaceuticals Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global SPECT Radiopharmaceuticals Product Life Cycle
- 3.3 Global SPECT Radiopharmaceuticals Sales by Manufacturers (2020-2025)
- 3.4 Global SPECT Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
- 3.5 SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global SPECT Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 SPECT Radiopharmaceuticals Market Competitive Situation and Trends
- 3.8.1 SPECT Radiopharmaceuticals Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest SPECT Radiopharmaceuticals Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 SPECT Radiopharmaceuticals Industry Chain Analysis
- 4.1 SPECT Radiopharmaceuticals Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of SPECT Radiopharmaceuticals Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global SPECT Radiopharmaceuticals Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to SPECT Radiopharmaceuticals Market
- 5.7 ESG Ratings of Leading Companies
- 6 SPECT Radiopharmaceuticals Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global SPECT Radiopharmaceuticals Sales Market Share by Type (2020-2025)
- 6.3 Global SPECT Radiopharmaceuticals Market Size by Type (2020-2025)
- 6.4 Global SPECT Radiopharmaceuticals Price by Type (2020-2025)
- 7 SPECT Radiopharmaceuticals Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global SPECT Radiopharmaceuticals Market Sales by Application (2020-2025)
- 7.3 Global SPECT Radiopharmaceuticals Market Size (M USD) by Application (2020-2025)
- 7.4 Global SPECT Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
- 8 SPECT Radiopharmaceuticals Market Sales by Region
- 8.1 Global SPECT Radiopharmaceuticals Sales by Region
- 8.1.1 Global SPECT Radiopharmaceuticals Sales by Region
- 8.1.2 Global SPECT Radiopharmaceuticals Sales Market Share by Region
- 8.2 Global SPECT Radiopharmaceuticals Market Size by Region
- 8.2.1 Global SPECT Radiopharmaceuticals Market Size by Region
- 8.2.2 Global SPECT Radiopharmaceuticals Market Size by Region
- 8.3 North America
- 8.3.1 North America SPECT Radiopharmaceuticals Sales by Country
- 8.3.2 North America SPECT Radiopharmaceuticals Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe SPECT Radiopharmaceuticals Sales by Country
- 8.4.2 Europe SPECT Radiopharmaceuticals Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific SPECT Radiopharmaceuticals Sales by Region
- 8.5.2 Asia Pacific SPECT Radiopharmaceuticals Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America SPECT Radiopharmaceuticals Sales by Country
- 8.6.2 South America SPECT Radiopharmaceuticals Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa SPECT Radiopharmaceuticals Sales by Region
- 8.7.2 Middle East and Africa SPECT Radiopharmaceuticals Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 SPECT Radiopharmaceuticals Market Production by Region
- 9.1 Global Production of SPECT Radiopharmaceuticals by Region(2020-2025)
- 9.2 Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
- 9.3 Global SPECT Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America SPECT Radiopharmaceuticals Production
- 9.4.1 North America SPECT Radiopharmaceuticals Production Growth Rate (2020-2025)
- 9.4.2 North America SPECT Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe SPECT Radiopharmaceuticals Production
- 9.5.1 Europe SPECT Radiopharmaceuticals Production Growth Rate (2020-2025)
- 9.5.2 Europe SPECT Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan SPECT Radiopharmaceuticals Production (2020-2025)
- 9.6.1 Japan SPECT Radiopharmaceuticals Production Growth Rate (2020-2025)
- 9.6.2 Japan SPECT Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China SPECT Radiopharmaceuticals Production (2020-2025)
- 9.7.1 China SPECT Radiopharmaceuticals Production Growth Rate (2020-2025)
- 9.7.2 China SPECT Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 GE Healthcare
- 10.1.1 GE Healthcare Basic Information
- 10.1.2 GE Healthcare SPECT Radiopharmaceuticals Product Overview
- 10.1.3 GE Healthcare SPECT Radiopharmaceuticals Product Market Performance
- 10.1.4 GE Healthcare Business Overview
- 10.1.5 GE Healthcare SWOT Analysis
- 10.1.6 GE Healthcare Recent Developments
- 10.2 Cardinal Health
- 10.2.1 Cardinal Health Basic Information
- 10.2.2 Cardinal Health SPECT Radiopharmaceuticals Product Overview
- 10.2.3 Cardinal Health SPECT Radiopharmaceuticals Product Market Performance
- 10.2.4 Cardinal Health Business Overview
- 10.2.5 Cardinal Health SWOT Analysis
- 10.2.6 Cardinal Health Recent Developments
- 10.3 Lantheus Medical Imaging
- 10.3.1 Lantheus Medical Imaging Basic Information
- 10.3.2 Lantheus Medical Imaging SPECT Radiopharmaceuticals Product Overview
- 10.3.3 Lantheus Medical Imaging SPECT Radiopharmaceuticals Product Market Performance
- 10.3.4 Lantheus Medical Imaging Business Overview
- 10.3.5 Lantheus Medical Imaging SWOT Analysis
- 10.3.6 Lantheus Medical Imaging Recent Developments
- 10.4 Bracco Imaging
- 10.4.1 Bracco Imaging Basic Information
- 10.4.2 Bracco Imaging SPECT Radiopharmaceuticals Product Overview
- 10.4.3 Bracco Imaging SPECT Radiopharmaceuticals Product Market Performance
- 10.4.4 Bracco Imaging Business Overview
- 10.4.5 Bracco Imaging Recent Developments
- 10.5 Curium Pharma
- 10.5.1 Curium Pharma Basic Information
- 10.5.2 Curium Pharma SPECT Radiopharmaceuticals Product Overview
- 10.5.3 Curium Pharma SPECT Radiopharmaceuticals Product Market Performance
- 10.5.4 Curium Pharma Business Overview
- 10.5.5 Curium Pharma Recent Developments
- 10.6 Eczacibasi-Monrol
- 10.6.1 Eczacibasi-Monrol Basic Information
- 10.6.2 Eczacibasi-Monrol SPECT Radiopharmaceuticals Product Overview
- 10.6.3 Eczacibasi-Monrol SPECT Radiopharmaceuticals Product Market Performance
- 10.6.4 Eczacibasi-Monrol Business Overview
- 10.6.5 Eczacibasi-Monrol Recent Developments
- 10.7 Siemens Healthineers
- 10.7.1 Siemens Healthineers Basic Information
- 10.7.2 Siemens Healthineers SPECT Radiopharmaceuticals Product Overview
- 10.7.3 Siemens Healthineers SPECT Radiopharmaceuticals Product Market Performance
- 10.7.4 Siemens Healthineers Business Overview
- 10.7.5 Siemens Healthineers Recent Developments
- 10.8 Bayer (Radiology Division)
- 10.8.1 Bayer (Radiology Division) Basic Information
- 10.8.2 Bayer (Radiology Division) SPECT Radiopharmaceuticals Product Overview
- 10.8.3 Bayer (Radiology Division) SPECT Radiopharmaceuticals Product Market Performance
- 10.8.4 Bayer (Radiology Division) Business Overview
- 10.8.5 Bayer (Radiology Division) Recent Developments
- 10.9 Molecular Imaging, Inc.
- 10.9.1 Molecular Imaging, Inc. Basic Information
- 10.9.2 Molecular Imaging, Inc. SPECT Radiopharmaceuticals Product Overview
- 10.9.3 Molecular Imaging, Inc. SPECT Radiopharmaceuticals Product Market Performance
- 10.9.4 Molecular Imaging, Inc. Business Overview
- 10.9.5 Molecular Imaging, Inc. Recent Developments
- 10.10 NorthStar Medical Radioisotopes
- 10.10.1 NorthStar Medical Radioisotopes Basic Information
- 10.10.2 NorthStar Medical Radioisotopes SPECT Radiopharmaceuticals Product Overview
- 10.10.3 NorthStar Medical Radioisotopes SPECT Radiopharmaceuticals Product Market Performance
- 10.10.4 NorthStar Medical Radioisotopes Business Overview
- 10.10.5 NorthStar Medical Radioisotopes Recent Developments
- 10.11 Advanced Accelerator Applications
- 10.11.1 Advanced Accelerator Applications Basic Information
- 10.11.2 Advanced Accelerator Applications SPECT Radiopharmaceuticals Product Overview
- 10.11.3 Advanced Accelerator Applications SPECT Radiopharmaceuticals Product Market Performance
- 10.11.4 Advanced Accelerator Applications Business Overview
- 10.11.5 Advanced Accelerator Applications Recent Developments
- 10.12 IBA Molecular Imaging
- 10.12.1 IBA Molecular Imaging Basic Information
- 10.12.2 IBA Molecular Imaging SPECT Radiopharmaceuticals Product Overview
- 10.12.3 IBA Molecular Imaging SPECT Radiopharmaceuticals Product Market Performance
- 10.12.4 IBA Molecular Imaging Business Overview
- 10.12.5 IBA Molecular Imaging Recent Developments
- 11 SPECT Radiopharmaceuticals Market Forecast by Region
- 11.1 Global SPECT Radiopharmaceuticals Market Size Forecast
- 11.2 Global SPECT Radiopharmaceuticals Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe SPECT Radiopharmaceuticals Market Size Forecast by Country
- 11.2.3 Asia Pacific SPECT Radiopharmaceuticals Market Size Forecast by Region
- 11.2.4 South America SPECT Radiopharmaceuticals Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of SPECT Radiopharmaceuticals by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global SPECT Radiopharmaceuticals Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of SPECT Radiopharmaceuticals by Type (2026-2035)
- 12.1.2 Global SPECT Radiopharmaceuticals Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of SPECT Radiopharmaceuticals by Type (2026-2035)
- 12.2 Global SPECT Radiopharmaceuticals Market Forecast by Application (2026-2035)
- 12.2.1 Global SPECT Radiopharmaceuticals Sales (K MT) Forecast by Application
- 12.2.2 Global SPECT Radiopharmaceuticals Market Size (M USD) Forecast by Application (2026-2035)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
